Partner Headlines - FOLD

  1. Amicus Therapeutics Stock Tumbles After FDA Setback

    TalkMarkets
  2. Mid-Day Market Update: Dow Surges Over 250 Points; Firstmerit ...

    Benzinga
  3. Mid-Afternoon Market Update: Oramed Jumps Following Announcement ...

    Benzinga
  4. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders ...

    GuruFocus
  5. Morning Market Gainers

    Benzinga
  6. Stock Futures Ride Global Surge; Early Risers: GE, Tenet Health

    IBD
  7. Benzinga's Top #PreMarket Gainers

    Benzinga
  8. Morning Market Losers

    Benzinga
  9. Amicus Therapeutics Provides U.S. Regulatory Update for Migalastat ...

    Benzinga
  10. Mid-Afternoon Market Update: Cracker Barrel Drops Following Q4 ...

    Benzinga
  11. Mid-Day Market Update: Crude Oil Surges Over 5%; Paycom Software ...

    Benzinga
  12. Mid-Morning Market Update: Markets Mixed; FedEx Earnings Miss ...

    Benzinga
  13. Benzinga's Top Downgrades

    Benzinga
  14. Benzinga's M&A Chatter for Monday August 31, 2015

    Benzinga
  15. Mid-Morning Market Update: Markets Gain; Finish Line Beats Q1 ...

    Benzinga
  16. Morning Market Gainers

    Benzinga
  17. Keep An Eye On These 10 After-Hours Movers

    Benzinga
  18. Pier 1, BioMarin, HomeAway & Oracle Lead Wednesday's After-Hours ...

    Benzinga
  19. Benzinga's Volume Movers

    Benzinga
  20. US Stock Futures Surge Ahead Of ADP Report, Beige Book

    Benzinga
  21. Amicus Therapeutics Submits Marketing Authorization Application ...

    Benzinga
  22. US Stock Futures Jump Ahead Of Wholesale Inventories Data

    Benzinga
  23. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  24. Morning Market Gainers

    Benzinga
  25. Pharmaceuticals, Therapeutics And A Retailer On The Move Thursday ...

    Benzinga
  26. Benzinga's Top #PreMarket Gainers

    Benzinga
  27. NPS Pharmaceuticals Spikes 19% Amid Shire Bid Report

    Benzinga
  28. These 4 Biotech Stocks Have Been On Fire

    Benzinga
  29. BioMarin Buying Prosensa, Backing Up Troubled Drug

    IBD
  30. Benzinga's Top #PreMarket Losers

    Benzinga
  31. Mid-Day Losers From November 18: Omega Protein, Urban Outfitters, ...

    Benzinga
  32. Mid-Afternoon Market Update: Tyson Rises After Q4 Results; DreamWorks ...

    Benzinga
  33. Mid-Day Market Update: Allergan Jumps On Actavis Bid; Denbury ...

    Benzinga
  34. Midday Gainers From November 17: Celldex Therapeutics, Amicus ...

    Benzinga
  35. Mid-Morning Market Update: Markets Edge Lower; Halliburton To ...

    Benzinga
  36. Morning Market Movers

    Benzinga
  37. Benzinga's Top #PreMarket Gainers

    Benzinga
  38. Top 5 Biotech Stocks Over The Past Year

    Benzinga
  39. 3 Cheap Biotech Stocks Analysts Love: Ohr Pharmaceutical Inc, ...

    Benzinga
  40. Top 5 Performing Biotech Stocks Of 2014

    Benzinga
  41. Morning Market Movers

    Benzinga
  42. The Biotech Stock With The Best One-Week Performance

    Benzinga
  43. Stocks Hitting 52-Week Highs

    Benzinga
  44. Morning Market Movers

    Benzinga
  45. Benzinga's Top #PreMarket Gainers

    Benzinga
  46. Morning Market Movers

    Benzinga
  47. Amicus Extending Rally On Upgrades

    Benzinga
  48. Benzinga's Top Upgrades

    Benzinga
  49. Benzinga's Top #PreMarket Gainers

    Benzinga
  50. Morning Market Movers

    Benzinga
  51. Benzinga's Top #PreMarket Gainers

    Benzinga
  52. Earnings Scheduled For March 3, 2014

    Benzinga
  53. UPDATE: J.P. Morgan Downgrades Amicus Therapeutics On Cautious ...

    Benzinga
  54. Gilead Sciences Leads In Rising Short Interest Among Biotechs ...

    Benzinga
  55. Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics ...

    Benzinga
  56. BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, ...

    Benzinga
  57. Amicus, Biogen Announce Deal for Discovery, Development, Commercialization ...

    Benzinga
  58. Amicus Therapeutics Says Added 6-Month Results from Phase 3 Fabry ...

    Benzinga
  59. Amicus Therapeutics Advances Chaperone-ERT Combo Platform in ...

    Benzinga
  60. Amicus Announces Positive Phase 2 Results for Chaperone-Enzyme ...

    Benzinga
  61. Stocks Hitting 52-Week Lows

    Benzinga
  62. UPDATE: Wedbush Downgrades Amicus Therapeutics to Underperform ...

    Benzinga
  63. Option Traders Call a Bottom for Amicus Therapeutics

    SchaeffersResearch
  64. GlaxoSmithKline

    IBD
  65. Amicus, Glaxo Release Top-Line Six-Month Primary Treatment Period ...

    Benzinga
  66. Amicus Therapeutics Announces Additional Preliminary Results ...

    Benzinga
  67. AMICUS THERAPEUTICS, INC. Reports Operating Results (10-Q)

    GuruFocus
  68. AMICUS THERAPEUTICS, INC. Reports Operating Results (10-Q)

    GuruFocus
  69. UPDATE: Canaccord Reiterates Buy Rating, Raises PT on Amicus ...

    Benzinga
  70. Amylin Pharmaceuticals, Best Buy Among Stocks Up on High Volume ...

    FoxBusiness
  71. Benzinga's Top Upgrades with Color for May 8, 2012

    Benzinga
  72. UPDATE: J.P. Morgan Upgrades Amicus Therapeutics

    Benzinga
  73. From Earlier: Amicus Therapeutics Prices Underwritten Offering ...

    Benzinga
  74. AMICUS THERAPEUTICS, INC. Reports Operating Results (10-K)

    GuruFocus
  75. Amicus Therapeutics Presents Preclinical Studies of Chaperone ...

    Benzinga
  76. Amicus Therapeutics Announces Positive Preliminary Results From ...

    Benzinga
Trading Center